SynthesisCardiovascular diabetology2025

Glucagon-like peptide-1 receptor agonist in myocardial infarction and atherosclerotic cardiovascular disease risk reduction: a comprehensive meta-analysis of number needed to treat, efficacy and safety.

Ansel Shao Pin Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.